MilliporeSigma invests over €300m in new South Korean bioprocessing center
MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has earmarked an investment exceeding €300 million for the establishment of a new Bioprocessing Production Center in Daejeon, South Korea. This significant investment underscores the company’s dedication to enhancing its capabilities within the rapidly evolving Asia-Pacific region, marking its […]